A novel M2e based flu vaccine formulation for dogs.
BACKGROUND:The USA 2004 influenza virus outbreak H3N8 in dogs heralded the emergence of a new disease in this species. A new inactivated H3N8 vaccine was developed to control the spread of the disease but, as in humans and swine, it is anticipated that the virus will mutate shift and drift in the do...
Main Authors: | Denis Leclerc, Marie Rivest, Cindy Babin, Constantino López-Macias, Pierre Savard |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3788766?pdf=render |
Similar Items
-
Improvement of the trivalent inactivated flu vaccine using PapMV nanoparticles.
by: Christian Savard, et al.
Published: (2011-01-01) -
Effectiveness of the flu vaccine to prevent severe flu
by: Francisco Miguel Escandell-Rico, et al.
Published: (2023-01-01) -
Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in humans following oral Ty21a vaccination: A randomized clinical trial.
by: Juan Manuel Carreño, et al.
Published: (2017-01-01) -
Salmonella infections and the host response
by: Constantino eLópez-Macías, et al.
Published: (2015-09-01) -
Universal Flu mRNA Vaccine: Promises, Prospects, and Problems
by: Andrei A. Deviatkin, et al.
Published: (2022-04-01)